Standardized allergenic · BLA
Oralair 100 IR NDC 59617-0010
Poa pratensis pollen 100 [IR]/1 + 4 more ingredients · Tablet, Orally disintegrating · Sublingual · Stallergenes
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 59617-0010-1 | 59617001001 | 1 BLISTER PACK in 1 BOX (59617-0010-1) / 3 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACKMarketed from Apr 30, 2014 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Oralair 100 IRSuffix: 100 IR
- Generic name (nonproprietary)
- anthoxanthum odoratum pollen, dactylis glomerata pollen, lolium perenne pollen, phleum pratense pollen, and poa pratensis pollen
- Active ingredients
- Poa pratensis pollen — 100 [IR]/1Dactylis glomerata pollen — 100 [IR]/1Anthoxanthum odoratum pollen — 100 [IR]/1Lolium perenne pollen — 100 [IR]/1Phleum pratense pollen — 100 [IR]/1
- Dosage form
- Tablet, Orally disintegrating
- Route
- Sublingual
- Labeler
- StallergenesNDC labeler code 59617
- Product type
- Standardized allergenic
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 125471
- Marketing start
- Listing expires
- Other FDA classes
- Allergens (Chemical structure)Allergens (Chemical structure)Allergens (Chemical structure)Allergens (Chemical structure)Cell-mediated Immunity (Physiologic effect)Cell-mediated Immunity (Physiologic effect)Cell-mediated Immunity (Physiologic effect)Cell-mediated Immunity (Physiologic effect)Increased Histamine Release (Physiologic effect)Increased Histamine Release (Physiologic effect)Increased Histamine Release (Physiologic effect)Increased Histamine Release (Physiologic effect)Increased IgG Production (Physiologic effect)Increased IgG Production (Physiologic effect)Increased IgG Production (Physiologic effect)Increased IgG Production (Physiologic effect)Pollen (Chemical structure)Pollen (Chemical structure)Pollen (Chemical structure)Pollen (Chemical structure)
- Identifiers
- Product ID 59617-0010_37291a56-277d-dd3a-e063-6294a90a7571SPL ID 37291a56-277d-dd3a-e063-6294a90a7571
- Pharmacologic class
- Standardized Pollen Allergenic Extract
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Sublingual products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N459617001001followed by a unit qualifier and the quantityPackage 59617-0010-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 59617-0010
- What is NDC 59617-0010?
- 59617-0010 is the product NDC for Oralair 100 IR, Poa pratensis pollen 100 [IR]/1 + 4 more ingredients tablet, orally disintegrating, listed with the FDA by Stallergenes. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Oralair 100 IR (ANTHOXANTHUM ODORATUM POLLEN, DACTYLIS GLOMERATA POLLEN, LOLIUM PERENNE POLLEN, PHLEUM PRATENSE POLLEN, and POA PRATENSIS POLLEN).
- What is the active ingredient?
- Poa pratensis pollen, Dactylis glomerata pollen, Anthoxanthum odoratum pollen, Lolium perenne pollen, Phleum pratense pollen.
- Who is the labeler?
- Stallergenes, NDC labeler code 59617. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Oralair 100 IR?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Other NDCs under BLA 125471
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Oralairanthoxanthum odoratum pollen, dactylis glomerata pollen, lolium perenne pollen, phelum pratense pollen, and poa pratensis pollen | — | Kit | Stallergenes | 59617-0020 |
| Oralairanthoxanthum odoratum pollen, dactylis glomerata pollen, lolium perenne pollen, phelum pratense pollen, and poa pratensis pollen | — | Kit | Stallergenes | 59617-0025 |
| Oralairanthoxanthum odoratum pollen, dactylis glomerata pollen, lolium perenne pollen, phelum pratense pollen, and poa pratensis pollen | — | Kit | CENEXI HSC | 82454-0020 |
| Oralairanthoxanthum odoratum pollen, dactylis glomerata pollen, lolium perenne pollen, phelum pratense pollen, and poa pratensis pollen | — | Kit | CENEXI HSC | 82454-0025 |
| Oralair 300 IRanthoxanthum odoratum pollen, dactylis glomerata pollen, lolium perenne pollen, phleum pratense pollen, and poa pratensis pollen | Dactylis glomerata pollen 300 [IR]/1 + 4 more ingredients | Tablet, Orally disintegratingSublingual | Stallergenes | 59617-0015 |
| Oralair 300 IRanthoxanthum odoratum pollen, dactylis glomerata pollen, lolium perenne pollen, phleum pratense pollen, and poa pratensis pollen | Poa pratensis pollen 300 [IR]/1 + 4 more ingredients | Tablet, Orally disintegratingSublingual | Stallergenes | 59617-0016 |
| Oralair 300 IRanthoxanthum odoratum pollen, dactylis glomerata pollen, lolium perenne pollen, phleum pratense pollen, and poa pratensis pollen | Dactylis glomerata pollen 300 [IR]/1 + 4 more ingredients | Tablet, Orally disintegratingSublingual | CENEXI HSC | 82454-0015 |